[go: up one dir, main page]

NO179472C - Solution comprising benzoxonium chloride for the treatment of contact lenses, and their use for preserving contact lenses and drugs for the eyes - Google Patents

Solution comprising benzoxonium chloride for the treatment of contact lenses, and their use for preserving contact lenses and drugs for the eyes

Info

Publication number
NO179472C
NO179472C NO904112A NO904112A NO179472C NO 179472 C NO179472 C NO 179472C NO 904112 A NO904112 A NO 904112A NO 904112 A NO904112 A NO 904112A NO 179472 C NO179472 C NO 179472C
Authority
NO
Norway
Prior art keywords
contact lenses
treatment
eyes
drugs
solution
Prior art date
Application number
NO904112A
Other languages
Norwegian (no)
Other versions
NO179472B (en
NO904112L (en
NO904112D0 (en
Inventor
Gyoergy Lajos Kis
Original Assignee
Ciba Geigy Ag
Ciba Vision Ag
Dispersa Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag, Ciba Vision Ag, Dispersa Ag filed Critical Ciba Geigy Ag
Publication of NO904112D0 publication Critical patent/NO904112D0/en
Publication of NO904112L publication Critical patent/NO904112L/en
Publication of NO179472B publication Critical patent/NO179472B/en
Publication of NO179472C publication Critical patent/NO179472C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Eyeglasses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Antimicrobial ophthalmic compositions containing compounds of the formula I <IMAGE> in which Ar, Alk, alk1, alk2, alk3 and X<(-)> are as defined in the description, and the use of these compounds of the formula I for preserving ophthalmic medicinal agents and for the treatment of contact lenses are disclosed.
NO904112A 1989-09-21 1990-09-20 Solution comprising benzoxonium chloride for the treatment of contact lenses, and their use for preserving contact lenses and drugs for the eyes NO179472C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH344689 1989-09-21

Publications (4)

Publication Number Publication Date
NO904112D0 NO904112D0 (en) 1990-09-20
NO904112L NO904112L (en) 1991-03-22
NO179472B NO179472B (en) 1996-07-08
NO179472C true NO179472C (en) 1996-10-16

Family

ID=4256126

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904112A NO179472C (en) 1989-09-21 1990-09-20 Solution comprising benzoxonium chloride for the treatment of contact lenses, and their use for preserving contact lenses and drugs for the eyes

Country Status (18)

Country Link
EP (1) EP0420798B1 (en)
JP (1) JP2960507B2 (en)
AT (1) ATE103182T1 (en)
AU (1) AU640687B2 (en)
CA (1) CA2025728C (en)
DD (1) DD299267A5 (en)
DE (1) DE59005084D1 (en)
DK (1) DK0420798T3 (en)
ES (1) ES2053161T3 (en)
FI (1) FI101849B (en)
HU (2) HUT59001A (en)
IE (1) IE71639B1 (en)
IL (1) IL95720A (en)
NO (1) NO179472C (en)
NZ (1) NZ235377A (en)
PH (1) PH29982A (en)
PT (1) PT95355B (en)
ZA (1) ZA907536B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037647A (en) * 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
JPH08510469A (en) * 1993-05-25 1996-11-05 オークランド ユニサービシーズ リミテッド Nitrobenzyl mustard quaternary salt and its use as hypoxia-selective cytotoxic agent
JP4849288B2 (en) * 2000-09-29 2012-01-11 ライオン株式会社 Eye drops and tear film stabilizer
JP2010031052A (en) * 2002-04-08 2010-02-12 Lion Corp Composition for ophthalmic use and antiseptic composition for ophthalmology preparation
US20050214382A1 (en) * 2004-03-29 2005-09-29 Erning Xia Zinc preservative composition and method of use
DE202005005094U1 (en) * 2005-03-31 2005-07-28 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Composition, useful for the treatment of diseases or conditions of eye, comprises extract and/or tincture obtained from plant and/or plant parts of Euphrasia officinalis, and sodium chloride
CN102227211A (en) * 2008-11-28 2011-10-26 先进控股有限公司 Pharmaceutical formulation comprising diclofenac and hydroxy fatty acid polyoxyalkylene ester
JP2012006962A (en) * 2011-08-22 2012-01-12 Lion Corp Ophthalmic composition
US20230347009A1 (en) * 2022-04-28 2023-11-02 Val Knight Disposable contact lens cleansing device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204836A1 (en) * 1973-09-24 1976-03-05 Allergan Pharma COMPOSITION TO STERILIZE SOFT CONTACT LENSES
DE3612537C1 (en) * 1986-04-14 1987-07-16 Dispersa Ag Medicines used to treat inflammation in the eye
NO175404C (en) * 1987-09-11 1994-10-12 Syntex Inc Process for the preparation of an eye preparation and preservative system for such a preparation

Also Published As

Publication number Publication date
FI101849B1 (en) 1998-09-15
PH29982A (en) 1996-10-29
NO179472B (en) 1996-07-08
NO904112L (en) 1991-03-22
JPH03130219A (en) 1991-06-04
PT95355B (en) 1997-06-30
ZA907536B (en) 1991-05-29
FI904616A0 (en) 1990-09-19
IE903406A1 (en) 1991-04-10
JP2960507B2 (en) 1999-10-06
AU640687B2 (en) 1993-09-02
ES2053161T3 (en) 1994-07-16
HU905995D0 (en) 1991-03-28
FI101849B (en) 1998-09-15
HU210525A9 (en) 1995-04-28
NO904112D0 (en) 1990-09-20
EP0420798A1 (en) 1991-04-03
DK0420798T3 (en) 1994-04-11
DE59005084D1 (en) 1994-04-28
NZ235377A (en) 1992-08-26
CA2025728C (en) 2002-02-26
DD299267A5 (en) 1992-04-09
CA2025728A1 (en) 1991-03-22
IL95720A0 (en) 1991-06-30
HUT59001A (en) 1992-04-28
PT95355A (en) 1991-05-22
IE71639B1 (en) 1997-02-26
AU6302490A (en) 1991-03-28
ATE103182T1 (en) 1994-04-15
EP0420798B1 (en) 1994-03-23
IL95720A (en) 1996-07-23

Similar Documents

Publication Publication Date Title
ATE248837T1 (en) QUINUCLIDINE-ACRYLAMIDE
NO890259L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ETHYLPHENOXYACETAMIDES.
DK0524781T3 (en) Therapeutic amides
NO902800D0 (en) PROCEDURE FOR THE PREPARATION OF 11BETA-ARYL-4-OESTERS.
NZ237309A (en) 1-(2-(4-morpholino)ethyl)-3-(arylcarbonyl)-indole derivatives and pharmaceutical compositions
NO179472C (en) Solution comprising benzoxonium chloride for the treatment of contact lenses, and their use for preserving contact lenses and drugs for the eyes
DE69218816D1 (en) Pharmaceutical composition containing N-acetyl-cysteine derivatives for the treatment of cataract
ITRM910730A1 (en) PHARMACEUTICAL COMPOSITIONS, FOR TOPICAL USE, CONTAINING &#34;SCAVENGERS&#34; OF FREE OXYGEN RADICALS AND ANTIBACTERIALS, INDICATED IN THE THERAPY OF SURFACE TISSUES.
PT1147105E (en) DERIVATIVES OF OPTICALLY ACTIVE PYRIDYL-4H-1,2,4-OXADIAZINE AND THEIR USE IN THE TREATMENT OF VASCULAR DISEASES
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
HUP0000110A2 (en) Pharmaceutical compositions comprising azacyclic, azabicyclic or tetrahydro-pyridine-derivatives suitable for treating pain
ATE5256T1 (en) PHENYLPIPERAZIN DERIVATIVES OF 1,3,4OXADIAZOLYLPENOLS, THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM.
DE3778642D1 (en) THERAPEUTIC FOR TREATMENT OF STOMACH.
NO922635D0 (en) NEW USE OF BENZIMIDAZOLINE-2-OXO-1-CARBOXYLIC ACID DERIVATIVES
DK0826373T3 (en) Preventive remedy for postoperative astigmatism
DK0453337T3 (en) Use of hexetidine or derivatives or salts thereof for the preparation of a pharmaceutical composition for ophthalmic use
DE59407576D1 (en) Use of etofibrate and pharmaceutical compositions containing etofibrate for the treatment of diabetic angio- and retinopathy
ITMI932219A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AN ACTIVE SUBSTANCE PHOSPHATIDILINOSITOL SUITABLE FOR THE THERAPY OF PERIPHERAL NEURPATHIES FROM
PT97878A (en) Process for the preparation of a pharmaceutical composition for ophthalmic use containing hexetidine or derivatives or salts thereof